{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:32:51Z","timestamp":1778124771851,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773740"],"award-info":[{"award-number":["81773740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81073119"],"award-info":[{"award-number":["81073119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81611130078"],"award-info":[{"award-number":["81611130078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2015\u2009A030313287"],"award-info":[{"award-number":["2015\u2009A030313287"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.phrs.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T04:28:08Z","timestamp":1550809688000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Sinomenine inhibits osteolysis in breast cancer by reducing IL-8\/CXCR1 and c-Fos\/NFATc1 signaling"],"prefix":"10.1016","volume":"142","author":[{"given":"Yueyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binhua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-3690","authenticated-orcid":false,"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-3044","authenticated-orcid":false,"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.02.015_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv360","article-title":"CAPG and GIPC1: breast cancer biomarkers for bone metastasis development and treatment","volume":"108","author":"Westbrook","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2019.02.015_bib0010","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1200\/JCO.2017.73.7437","article-title":"Cost-effectiveness analysis of monthly zoledronic acid, zoledronic acid every 3 months, and monthly denosumab in women with breast cancer and skeletal metastases: CALGB 70604 (Alliance)","volume":"35","author":"Shapiro","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrrheum.2014.198","article-title":"Mellins ED. Alternative pathways of osteoclastogenesis in inflammatory arthritis","volume":"11","author":"Adamopoulos","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0020","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.phrs.2019.02.015_bib0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrendo.2016.91","article-title":"Physiological and pathophysiological bone turnover - role of the immune system","volume":"12","author":"Weitzmann","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12178-009-9046-7","article-title":"RANK, RANKL and osteoprotegerin in bone biology and disease","volume":"2","author":"Wright","year":"2009","journal-title":"Curr. Rev. Musculoskeletal Med."},{"key":"10.1016\/j.phrs.2019.02.015_bib0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bcp.2016.02.013","article-title":"Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo","volume":"104","author":"Zhu","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.actbio.2017.08.046","article-title":"Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-kappaB signaling","volume":"62","author":"Ping","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2019.02.015_bib0045","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1039\/C7NR04365A","article-title":"Fullerenol nanoparticles suppress RANKL-induced osteoclastogenesis by inhibiting differentiation and maturation","volume":"9","author":"Geng","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.phrs.2019.02.015_bib0050","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/jbmr.3031","article-title":"TRAF6 mediates suppression of osteoclastogenesis and prevention of ovariectomy-induced bone loss by a novel prenylflavonoid","volume":"32","author":"Tan","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res.: BCR"},{"key":"10.1016\/j.phrs.2019.02.015_bib0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/bcr2835","article-title":"Therapeutic targets for bone metastases in breast cancer","volume":"13","author":"Clezardin","year":"2011","journal-title":"Breast Cancer Res.: BCR"},{"key":"10.1016\/j.phrs.2019.02.015_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/jsre.2001.6204","article-title":"Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells","volume":"100","author":"Mancino","year":"2001","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2018.01.003","article-title":"Breast cancer bone metastases: pathogenesis and therapeutic targets","author":"Brook","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-006-9438-y","article-title":"RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer","volume":"105","author":"Lau","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2019.02.015_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12016-015-8523-6","article-title":"Non-canonical (RANKL-independent) pathways of osteoclast differentiation and their role in musculoskeletal diseases","volume":"51","author":"Sabokbar","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0085","first-page":"5849","article-title":"Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity","volume":"59","author":"Pederson","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bone.2014.01.015","article-title":"Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans","volume":"61","author":"Kamalakar","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2019.02.015_bib0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone metastasis: the importance of the neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2019.02.015_bib0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/j.1875-9114.2011.01092.x","article-title":"Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor","volume":"32","author":"Iranikhah","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.phrs.2019.02.015_bib0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2016.19425","article-title":"Effect of longer-interval vs standard dosing of zoledronic acid on skeletal events in patients with bone metastases: a randomized clinical trial","volume":"317","author":"Himelstein","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2019.02.015_bib0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(13)70174-8","article-title":"Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial","volume":"14","author":"Amadori","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study","volume":"14","author":"Chawla","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10354-016-0437-2","article-title":"[Position paper on medication-related osteonecrosis of the jaw (MRONJ)]","volume":"166","author":"Svejda","year":"2016","journal-title":"Wiener medizinische Wochenschrift"},{"key":"10.1016\/j.phrs.2019.02.015_bib0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00520-018-4060-1","article-title":"Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Menshawy","year":"2018","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.phrs.2019.02.015_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/jcm2030067","article-title":"bone-targeted agents for the management of breast cancer patients with bone metastases","volume":"2","author":"Simos","year":"2013","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2019.02.015_bib0135","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1038\/srep07270","article-title":"Antinociceptive effects of sinomenine in a rat model of neuropathic pain","volume":"4","author":"Zhu","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2019.02.015_bib0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2017.06.024","article-title":"Sinomenine produces peripheral analgesic effects via inhibition of voltage-gated sodium currents","volume":"358","author":"Lee","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2019.02.015_bib0145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4062\/biomolther.2017.157","article-title":"Sinomenine, an alkaloid derived from sinomenium acutum potentiates pentobarbital-induced sleep behaviors and non-rapid eye movement (NREM) sleep in rodents","volume":"25","author":"Yoo","year":"2017","journal-title":"Biomol. Therapeut."},{"key":"10.1016\/j.phrs.2019.02.015_bib0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.phrs.2017.08.014","article-title":"Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-kappaB signaling","volume":"125","author":"Huang","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bcp.2017.07.010","article-title":"Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis","volume":"142","author":"Zhou","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0160","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopha.2017.11.123","article-title":"Sinomenine hydrochloride attenuates the proliferation, migration, invasiveness, angiogenesis and epithelial-mesenchymal transition of clear-cell renal cell carcinoma cells via targeting Smad in vitro","volume":"96","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2019.02.015_bib0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbrc.2015.07.004","article-title":"Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-kappaB activation mediated by IL-4\/miR-324-5p\/CUEDC2 axis","volume":"464","author":"Song","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.02.015_bib0170","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3892\/ol.2016.4768","article-title":"Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway","volume":"12","author":"Jiang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phrs.2019.02.015_bib0175","first-page":"1","article-title":"Synthesis and antitumor activities of sinomenine derivatives on rings A and C","author":"Wei","year":"2017","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2016.03.014","article-title":"Sinomenine down-regulates TLR4\/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis","volume":"779","author":"He","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0185","article-title":"Sinomenine suppresses osteoclast formation and mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2019.02.015_bib0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/aps.2013.139","article-title":"Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2019.02.015_bib0195","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopha.2017.03.084","article-title":"Influence of sinomenine upon mesenchymal stem cells in osteoclastogenesis","volume":"90","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2019.02.015_bib0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.intimp.2013.11.014","article-title":"A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines","volume":"18","author":"Sun","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0205","first-page":"1107","article-title":"[Effects of sinomenine and methotrexate on fibroblast-like synoviocytes in rheumatoid arthritis]","volume":"32","author":"Sun","year":"2012","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi."},{"key":"10.1016\/j.phrs.2019.02.015_bib0210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/aps.2013.152","article-title":"Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice","volume":"35","author":"Yan","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2019.02.015_bib0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jbmr.2612","article-title":"WHI-131 promotes osteoblast differentiation and prevents osteoclast formation and resorption in mice","volume":"31","author":"Cheon","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0220","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0225","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","article-title":"Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss","volume":"75","author":"Krishnamurthy","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2019.02.015_bib0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2019.02.015_bib0235","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2019.02.015_bib0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.addr.2014.10.014","article-title":"In vitro microenvironments to study breast cancer bone colonisation","volume":"79\u201380","author":"Taubenberger","year":"2014","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.phrs.2019.02.015_bib0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.02.015_bib0250","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2019.02.015_bib0255","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.ajpath.2016.04.003","article-title":"Effects of IL-8 up-regulation on cell survival and osteoclastogenesis in multiple myeloma","volume":"186","author":"Herrero","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0260","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI117450","article-title":"Long-term impaired neutrophil migration in mice overexpressing human interleukin-8","volume":"94","author":"Simonet","year":"1994","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2019.02.015_bib0265","doi-asserted-by":"crossref","first-page":"e6932","DOI":"10.1097\/MD.0000000000006932","article-title":"Association between interleukin-8 levels and chronic periodontal disease: a PRISMA-compliant systematic review and meta-analysis","volume":"96","author":"Finoti","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2019.02.015_bib0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13684730050515796","article-title":"Interleukin\u20136 and interleukin\u20138 levels in serum and synovial fluid of patients with osteoarthritis","volume":"6","author":"Kaneko","year":"2000","journal-title":"Cytokines Cell. Mol. Ther."},{"key":"10.1016\/j.phrs.2019.02.015_bib0275","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1210\/endo.139.10.6247","article-title":"Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8","volume":"139","author":"Rothe","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2019.02.015_bib0280","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.4049\/jimmunol.167.9.5381","article-title":"Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"167","author":"Nanki","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0285","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.berh.2016.02.006","article-title":"HLA and anti-citrullinated protein antibodies: building blocks in RA","volume":"29","author":"van der Woude","year":"2015","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.phrs.2019.02.015_bib0290","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2019.02.015_bib0295","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1535-7163.MCT-11-0731","article-title":"Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signaling","volume":"11","author":"Sung","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.phrs.2019.02.015_bib0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2016.10.007","article-title":"Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCgamma1-Ca(2+)-NFATc1 signaling pathway and prevents ovariectomy-induced bone loss","volume":"124","author":"Zeng","year":"2017","journal-title":"Biochem. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818315184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818315184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:50:44Z","timestamp":1721004644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818315184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":60,"alternative-id":["S1043661818315184"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.02.015","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sinomenine inhibits osteolysis in breast cancer by reducing IL-8\/CXCR1 and c-Fos\/NFATc1 signaling","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}